Skip to main content
Clinical Trials/NCT03186599
NCT03186599UnknownNot Applicable

Analysis of Initial Adherence and Its Impact on Long-term Adherence to Hormonal Therapy for Breast Cancer

Gachon University1 site in 1 country200 target enrollmentStarted: June 8, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Enrollment
200
Locations
1
Primary Endpoint
physical activity (daily steps)

Study Overview

Brief Summary

A trial will be conducted on 200 breast cancer patients with adjuvant hormonal therapy. The study included 6 months baseline measurement, and 12 months intervention. Patients will be assigned to high adherence or low adherence group. Then, through randomization, low adherence patients will be assigned to the intervention or control group. Study Coordinator delivers the intervention using the WALKON mobile application. Control participants receive usual care with continuous monitoring using Medication Event Monitoring System (MEMS) device.

Detailed Description

  • Baseline measurement (n=200): screening and enrollment
  • 3-month visit: collecting MEMS data
  • 6-month visit: collecting MEMS data and assigned to the high adherence (n=70) or low adherence group (n=75). The low adherence intervention group (n=75) will be educated about the WALKON mobile application.
  • 12-month visit: Control group: collecting MEMS data intervention group: monthly calls + collecting MEMS data
  • 18-month visit: collecting MEMS data and interview

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
20 Years to 70 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Stage 0-III breast cancer
  • Treated with Adjuvant hormonal therapy

Exclusion Criteria

  • Stage IV breast cancer
  • Breast cancer recurrence or metastasis
  • Severe medical illness

Arms & Interventions

high adherence control group

No Intervention

-Patients on continuous MEMS monitoring with usual care.

low adherence control group

No Intervention

-Patients on continuous MEMS monitoring with usual care.

low adherence intervention group

Experimental
  • Patient with the WALKON mobile application.
  • Patient with monthly feedback call
  • Patients on continuous MEMS monitoring.

Intervention: low adherence intervention group (Behavioral)

Outcomes

Primary Outcomes

physical activity (daily steps)

Time Frame: 12 months

Comparison of daily steps using WALKON application

Secondary Outcomes

  • Medication adherence using MEMS device(18 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Yul Ha Min

Assistant professor

Gachon University

Study Sites (1)

Loading locations...

Similar Trials